T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
NetApp
NTAP
$40.2B
| $14.5M | ﹤0.01% |
531,312
+10,240
| +2% | +$248K |
|
|
SYNH
1177
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14.5M | ﹤0.01% |
351,075
+139,845
| +66% | +$5.76M |
|
|
TCF
1178
DELISTED
TCF Financial Corporation
TCF
| $14.3M | ﹤0.01% |
1,162,702
-936,121
| -45% | -$11.2M |
|
|
CAA
1179
DELISTED
CalAtlantic Group, Inc.
CAA
| $14.2M | ﹤0.01% |
426,106
-2,240
| -0.5% | -$70.1K |
|
1180
Weyco Group
WEYS
$446M
| $14.1M | ﹤0.01% |
529,140
-30,930
| -6% | -$797K |
|
|
GNMK
1181
DELISTED
GenMark Diagnostics, Inc
GNMK
| $14.1M | ﹤0.01% |
2,670,154
+87,300
| +3% | +$486K |
|
1182
Jazz Pharmaceuticals
JAZZ
$16B
| $14.1M | ﹤0.01% |
107,707
-270,857
| -72% | -$33.7M |
|
|
NTUS
1183
DELISTED
Natus Medical Inc
NTUS
| $14M | ﹤0.01% |
365,130
+21,640
| +6% | +$806K |
|
1184
Fluor
FLR
$6.96B
| $14M | ﹤0.01% |
259,914
-2,710
| -1% | -$127K |
|
1185
Huron Consulting
HURN
$2.47B
| $13.9M | ﹤0.01% |
239,144
-12,600
| -5% | -$696K |
|
|
NAME
1186
DELISTED
Rightside Group, Ltd.
NAME
| $13.9M | ﹤0.01% |
1,722,296
+74,476
| +5% | +$628K |
|
1187
Unum
UNM
$14.5B
| $13.9M | ﹤0.01% |
448,338
-20
| -0% | -$587 |
|
1188
Nasdaq
NDAQ
$53.5B
| $13.9M | ﹤0.01% |
626,490
-3,480
| -0.6% | -$71.6K |
|
|
JWN
1189
DELISTED
Nordstrom
JWN
| $13.9M | ﹤0.01% |
242,219
-3,600
| -1% | -$186K |
|
1190
Polaris
PII
$3.9B
| $13.8M | ﹤0.01% |
139,904
-12,600
| -8% | -$1.09M |
|
1191
TETRA Technologies
TTI
$1.29B
| $13.7M | ﹤0.01% |
2,164,180
-567,310
| -21% | -$3.32M |
|
|
VAR
1192
DELISTED
Varian Medical Systems, Inc.
VAR
| $13.7M | ﹤0.01% |
195,313
-2,748
| -1% | -$187K |
|
1193
iShares MSCI Indonesia ETF
EIDO
$484M
| $13.5M | ﹤0.01% |
+573,900
| New | +$12.7M |
|
1194
Ziff Davis
ZD
$1.92B
| $13.4M | ﹤0.01% |
250,654
+11,086
| +5% | +$671K |
|
|
AKRX
1195
DELISTED
Akorn Inc
AKRX
| $13.4M | ﹤0.01% |
569,202
+49,810
| +10% | +$1.31M |
|
|
BWLD
1196
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $13.4M | ﹤0.01% |
90,350
-2,100
| -2% | -$321K |
|
1197
US Physical Therapy
USPH
$1.22B
| $13.4M | ﹤0.01% |
269,030
+10,100
| +4% | +$502K |
|
|
ONC
1198
BeOne Medicines Ltd
ONC
$40.6B
| $13.3M | ﹤0.01% |
+452,700
| New | +$12.8M |
|
|
CMA
1199
DELISTED
Comerica
CMA
| $13.2M | ﹤0.01% |
349,296
-425,577
| -55% | -$15.3M |
|
|
HAPN
1200
Happen Inc
HAPN
$2.27B
| $13.2M | ﹤0.01% |
316,941
-17,401
| -5% | -$730K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.